Naturally acquired antibodies target the glutamate-rich protein on intact merozoites and predict protection against febrile malaria

Journal of Infectious Diseases

Volumn 215, Issue 4, 2017, Pages 623-630

  Kana, Ikhlaq Hussain ^a,b   Adu, Bright ^c   Tiendrebeogo, R Wendpayangde ^a,b   Singh, Susheel Kumar ^a,b   Dodoo, Daniel ^c   Theisen, Michael ^a,b  

^a National Serum Institute   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University of Ghana   (Ghana)

Author keywords

antibody; GLURP; immunity; Malaria; MSP3; OP; Plasmodium falciparum

Indexed keywords

GLUTAMATE RICH PROTEIN; GLUTAMIC ACID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; PROTEIN; UNCLASSIFIED DRUG; GLUTAMATE-RICH PROTEIN, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ADAPTIVE IMMUNITY; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MEROZOITE; NATURALLY ACQUIRED IMMUNITY; NONHUMAN; PHAGOCYTOSIS; PREDICTION; PROTEIN TARGETING; BLOOD; FEVER; FOLLOW UP; GHANA; IMMUNOLOGY; INFANT; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEVER; FOLLOW-UP STUDIES; GHANA; HUMANS; IMMUNOGLOBULIN G; INFANT; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALARIA; MEROZOITES; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PROPORTIONAL HAZARDS MODELS; PROTOZOAN PROTEINS;

EID: 85017000763     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw617     Document Type: Article

References (35)

1. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006; 28:51-60.
2. Sergent E. [Definition of immunity & premunition]. Ann Inst Pasteur (Paris) 1950; 79:786-97.
3. Perignon JL, Druilhe P. Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 1994; 89 Suppl 2:51-3.
4. McGregor IA, Carrington SP, Cohen S. Treatment of East African P. falciparum malaria with West African gammaglobulin. Trans R Soc Trop Med Hyg 1963; 57:170-5.
5. Sabchareon A, Burnouf T, Ouattara D, et al. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 1991; 45:297-308.
6. Celada A, Cruchaud A, Perrin LH. Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes. J Parasitol 1983; 69:49-53.
7. Druilhe P, Khusmith S. Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect Immun 1987; 55:888-91.
8. Celada A, Cruchaud A, Perrin LH. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin Exp Immunol 1982; 47:635-44.
9. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990; 172:1633-41.
10. Crompton PD, Kayala MA, Traore B, et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 2010; 107:6958-63.
11. Richards JS, Arumugam TU, Reiling L, et al. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J Immunol 2013; 191:795-809.
12. Beeson JG, Drew DR, Boyle MJ, Feng G, Fowkes FJ, Richards JS. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol Rev 2016; 40:343-72.
13. Osier FH, Fegan G, Polley SD, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008; 76:2240-8.
14. Richards JS, Stanisic DI, Fowkes FJ, et al. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis 2010; 51:e50-60.
15. Oeuvray C, Theisen M, Rogier C, Trape JF, Jepsen S, Druilhe P. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. Infect Immun 2000; 68:2617-20.
16. Roussilhon C, Oeuvray C, Muller-Graf C, et al. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med 2007; 4:e320.
17. Taylor RR, Allen SJ, Greenwood BM, Riley EM. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg 1998; 58:406-13.
18. Stanisic DI, Richards JS, McCallum FJ, et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 2009; 77:1165-74.
19. Hill DL, Eriksson EM, Li Wai Suen CS, et al. Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria. PLoS One 2013; 8:e74627.
20. Osier FH, Feng G, Boyle MJ, et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med 2014; 12:108.
21. Oeuvray C, Bouharoun-Tayoun H, Grass-Masse H, et al. A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. Mem Inst Oswaldo Cruz 1994; 89 Suppl 2:77-80.
22. Theisen M, Soe S, Oeuvray C, et al. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun 1998; 66:11-7.
23. McCarthy JS, Marjason J, Elliott S, et al. A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide ISA 720. PLoS One 2011; 6:e24413.
24. Adu B, Dodoo D, Adukpo S, et al. Fc receptor IIIB (FcRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children. PLoS One 2012; 7:e46197.
25. Jogdand PS, Singh SK, Christiansen M, Dziegiel MH, Singh S, Theisen M. Flow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition. Malar J 2012; 11:235.
26. Tiendrebeogo RW, Adu B, Singh SK, et al. Antibody-dependent cellular inhibition is associated with reduced risk against febrile malaria in a longitudinal cohort study involving Ghanaian children. Open Forum Infect Dis 2015; 2:1-5.
27. Theisen M, Soe S, Jessing SG, et al. Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Vaccine 2000; 19:204-12.
28. Tiendrebeogo RW, Adu B, Singh SK, et al. High-throughput tri-colour flow cytometry technique to assess Plasmodium falciparum parasitaemia in bioassays. Malar J 2014; 13:412.
29. Jepsen MP, Jogdand PS, Singh SK, et al. The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas. J Infect Dis 2013; 208:479-88.
30. Adu B, Jepsen MP, Gerds TA, et al. Fc gamma receptor 3B (FCGR3Bc. 233C>A-rs5030738) polymorphism modifies the protective effect of malaria specific antibodies in Ghanaian children. J Infect Dis 2014; 209:285-9.
31. Hill DL, Wilson DW, Sampaio NG, et al. Merozoite antigens of Plasmodium falciparum elicit strain-transcending opsonizing immunity. Infect Immun 2016; 84:2175-84.
32. Tebo AE, Kremsner PG, Luty AJ. Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp Parasitol 2001; 98:20-8.
33. Ladda R, Aikawa M, Sprinz H. Penetration of erythrocytes by merozoites of mammalian and avian malarial parasites. J Parasitol 1969; 55:633-44.
34. Bannister LH, Butcher GA, Dennis ED, Mitchell GH. Structure and invasive behaviour of Plasmodium knowlesi merozoites in vitro. Parasitology 1975; 71:483-91.
35. Sirima SB, Mordmuller B, Milligan P, et al. A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. Vaccine 2016; 34:4536-42.